Brief: Processa Pharmaceuticals To Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based On FDA Guidance And Project Optimus Oncology Initiative

Processa Pharmaceuticals

18/05/2023 13:08

May 18 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS TO CONDUCT NEXT GENERATION
CHEMOTHERAPY-CAPECITABINE PHASE 2 TRIAL BASED ON FDA GUIDANCE
AND PROJECT OPTIMUS ONCOLOGY INITIATIVE
    * PROCESSA PHARMACEUTICALS TO CONDUCT NEXT GENERATION
CHEMOTHERAPY-CAPECITABINE PHASE 2 TRIAL BASED ON FDA GUIDANCE
AND PROJECT OPTIMUS ONCOLOGY INITIATIVE

Source text for Eikon:  ID:nGNX5ZJk0h 
Further company coverage:  PCSA.O 

 ((Reuters.Brief@thomsonreuters.com;))